prednisone,ibrutinib,venetoclax,obinutuzumab,lenalidomide
abbvie,janssen,roche,jubilant cadista pharma
['vipor', 'lymsm']
congress | #ash22 shares data on the vipor regimen in patients with r/r #fl. the combination appears to be safe and effective in this patient group. orr=100%, cr=79%. mrd was predictive of pfs in pet cr pts at eot. #lymsm #medicalcongress 
A global education platform providing clinical updates on a range of lymphoma subtypes and chronic lymphocytic leukemia (#CLL) #lymsm